Article
Flumequine enhances the in vivo mutagenicity of MeIQx in the mouse liver.
Archives of toxicology - 1 Aug 2013
Kuroda K, Kijima A, Ishii Y, Takasu S, Jin M, Matsushita K, Kodama Y, Umemura T
Abstract excerpt
The combined effects of various carcinogens found in food products are a concern for human health. In the present study, the effects of flumequine (FL) on the in vivo mutagenicity of 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline (MeIQx) in the liver were investigated. Additionally, we attempted to clarify the underlying mechanisms through comprehensive gene analysis using a cDNA microarray. Male gpt delta mice...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
